These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19754399)

  • 1. Parkinson's disease.
    Dinges J
    Curr Top Med Chem; 2009; 9(10):854. PubMed ID: 19754399
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerning neuroprotective therapy for Parkinson's disease.
    Uitti RJ; Wszolek ZK
    J Neural Transm Suppl; 2006; (70):433-7. PubMed ID: 17017564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advance in studies on pathological mechanism of Parkinson's disease and traditional Chinese medicine experiments in prevention and treatment of Parkinson's disease].
    Xiong P; Chen X; Zhang N
    Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(5):686-91. PubMed ID: 22693916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease.
    Mukherjee D; Hastie IR
    Postgrad Med J; 1995 Apr; 71(834):201-3. PubMed ID: 7784275
    [No Abstract]   [Full Text] [Related]  

  • 5. New hope for mechanism-based treatment of Parkinson's disease.
    Bradbury J
    Drug Discov Today; 2005 Jan; 10(2):80-1. PubMed ID: 15718152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe ataxic polyneuropathy associated with chronic levodopa use in Parkinson's disease.
    Kimber T; Blumbergs P; Thompson P
    Parkinsonism Relat Disord; 2013 Sep; 19(9):847-9. PubMed ID: 23746939
    [No Abstract]   [Full Text] [Related]  

  • 7. Levodopa delivery systems for the treatment of Parkinson's disease: an overview.
    Goole J; Amighi K
    Int J Pharm; 2009 Oct; 380(1-2):1-15. PubMed ID: 19651197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parkinson's syndrome. Etiopathogenesis and possibilities of treatment].
    Jovicić A
    Vojnosanit Pregl; 1985; 42(3):206-10. PubMed ID: 3895730
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidative stress and neuroinflammation in the story of Parkinson's disease: Could targeting these pathways write a good ending?
    Hassanzadeh K; Rahimmi A
    J Cell Physiol; 2018 Jan; 234(1):23-32. PubMed ID: 30078201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuating off-period hemidystonia with Pisa syndrome in advanced Parkinson's disease.
    Meloni M; Cannas A; Mascia MM; Solla P; Floris G; Di Stefano F; Marrosu F
    J Neurol Sci; 2016 Aug; 367():138-9. PubMed ID: 27423577
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurological aspects and modern trends in therapy of Parkinson's disease].
    Pavoncello S; Di Bianco V; Di Castro A; Caviglia A; Cellitti M
    Clin Ter; 1980 Feb; 92(4):433-8. PubMed ID: 7449321
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease and dementia with Lewy bodies.
    Scott L
    Elder Care; 1999 Jun; 11(4):37-9. PubMed ID: 10614276
    [No Abstract]   [Full Text] [Related]  

  • 13. [The origin of Parkinson's disease].
    Rinne J
    Duodecim; 1997; 113(18):1819-24. PubMed ID: 10892075
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis and treatment of Parkinson's disease in the elderly].
    Yanagisawa N
    Nihon Ronen Igakkai Zasshi; 1993 Dec; 30(12):1018-25. PubMed ID: 8114337
    [No Abstract]   [Full Text] [Related]  

  • 15. [Parkinson's disease].
    de Saxce H
    Rev Infirm; 1979 Jan; 29(1):50-7. PubMed ID: 252780
    [No Abstract]   [Full Text] [Related]  

  • 16. The variability of levodopa response in Parkinson's disease: is sensitization reversible?
    Jabre MG; Bejjani BP
    Mov Disord; 2008 Apr; 23(6):924; author reply 925. PubMed ID: 18163452
    [No Abstract]   [Full Text] [Related]  

  • 17. Parkinson's disease, Huntington's disease and tardive dyskinesia. Neurochemical pathology and treatment.
    Tolosa ES
    Minn Med; 1979 Feb; 62(2):101-6. PubMed ID: 155195
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of inflammation in the pathogenesis of Parkinson's disease: models, mechanisms, and therapeutic interventions.
    Hong JS
    Ann N Y Acad Sci; 2005 Aug; 1053():151-2. PubMed ID: 16179518
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bromocriptine (Parlodel) in the treatment of Parkinson's disease. Summary of 7 years' experience].
    Delwaide PJ; Schoenen J
    Rev Med Liege; 1983 May; 38(9):362-6. PubMed ID: 6867529
    [No Abstract]   [Full Text] [Related]  

  • 20. Levodopa efficacy and pathological basis of Parkinson syndrome.
    Rajput AH; Rozdilsky B; Rajput A; Ang L
    Clin Neuropharmacol; 1990 Dec; 13(6):553-8. PubMed ID: 2276120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.